How a simple nasal swab could help a Peninsula company redefine lung cancer risk

A swab of the nose could help doctors triage lung cancer patients to determine who need a closer look and who can skip time-consuming, stress-inducing, expensive and invasive procedures. Veracyte Inc. (NASDAQ: VCYT) of South San Francisco said Monday that a study of its Percepta nasal swab test...

Click to view original post